PlusTherapeuticsInc . (NASDAQ:PSTV) Stock Price Up 7.4%

Share on StockTwits

PlusTherapeuticsInc . (NASDAQ:PSTV) shares rose 7.4% on Monday . The company traded as high as $2.19 and last traded at $2.17, approximately 281,159 shares traded hands during mid-day trading. A decline of 0% from the average daily volume of 281,281 shares. The stock had previously closed at $2.02.

Separately, ValuEngine raised shares of PlusTherapeuticsInc . from a “hold” rating to a “buy” rating in a research note on Tuesday, September 24th.

The company has a debt-to-equity ratio of 4.28, a quick ratio of 1.54 and a current ratio of 1.54. The firm’s 50 day simple moving average is $2.36.

PlusTherapeuticsInc . (NASDAQ:PSTV) last issued its earnings results on Thursday, November 14th. The company reported ($0.03) earnings per share for the quarter, topping the consensus estimate of ($5.85) by $5.82. PlusTherapeuticsInc . had a negative net margin of 203.18% and a negative return on equity of 1,037.22%. The company had revenue of $4.77 million during the quarter.

A hedge fund recently bought a new stake in PlusTherapeuticsInc . stock. Sabby Management LLC acquired a new position in PlusTherapeuticsInc . (NASDAQ:PSTV) in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 113,600 shares of the company’s stock, valued at approximately $389,000. Sabby Management LLC owned 25.24% of PlusTherapeuticsInc . as of its most recent SEC filing. Institutional investors and hedge funds own 88.89% of the company’s stock.

About PlusTherapeuticsInc . (NASDAQ:PSTV)

Plus Therapeutics, Inc, a clinical-stage pharmaceutical company, engages in developing treatments for cancer and other diseases in the United States. The company's lead product candidate in pipeline is DocePLUS, an albumin-stabilized PEGylated liposomal formulation of docetaxel for the treatment of small cell lung cancer.

Further Reading: Bollinger Bands

Receive News & Ratings for PlusTherapeuticsInc . Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PlusTherapeuticsInc . and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2020 BBNS.